Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Stillpoint, perhaps you would be content to get no response from
Actually, that's true, but it's ALSO true that any PR that TPL issues regarding the MMP has to be reviewed and approved by PTSC. Read the master agreement. Therefore, there is NO excuse for one being able to issue a PR before the other.
Share
New Message
Please login to post a reply